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To identify proteinases responsible for fibronectin degrada-
tion in the wound environment we studied wound fluid ob-
tained from burn patients. Immunoblotting experiments 
showed that extensive degradation of fibronectin had oc-
curred in some burn wound fluid samples, in which case 
intact fibronectin molecules were undetectable, and the larg-
est fibronectin fragment was 116 kDa. The 116-kDa frag-
ment as well as a smaller 90-kDa fragment contained the 
fibronectin cell binding domain. These burn-fluid samples 
degraded freshly added fibronectin. Activity of the fibronec-
tin-degrading enzyme was blocked by a broad-spectrum ser-
ine proteinase inhibitor or by sp~cific .ne~t~ophil e~ast~s7 in-
hibitors but not by metalloprotell1ase lI1hlbltors or 1I11ubltors 
N ormal wound healing requires precise temporal and spatial regulation of cell adhesion proteins, proteinases, and growth factors, and inappropriate expression of any of these factors could result in abnormal healing [1,2] . In our research we have 
focused on the cell adhesion protein fibronectin and the various 
ro les that fibronectin plays in wound repair [3,4]. Fibronectin is 
deposited at the wound interface at the time of initial wounding and 
subequently becomes part of the provisional matrix [5,6]. 
Recently, we began experiments aimed at characterizing fibro-
nectin and its possible proteolysis in the wound environment. We 
fo und that wound fluid from chronic venous stasis ulcers contains 
degraded fibronectin [7,8] and activated metalloproteinases [9]. 
Because fibronectin is important for keratinocyte migration and 
wound re-epithelization [10], persistent degradation of fibronectin 
and other extracellular matrix components could be a factor in failed 
wound closure [11]. 
To learn whether fibronectin degradation occurs in acute trau-
matic wounds, we studied wound fluid obtained from burn patients. 
plasma fibronectin decreases markedly after burn injury [12], and 
some fibronectin fragments can be detected in the blood [13]. Previ-
ously, we found that gelsolin degradation occurred in some burn-
wound-fluid samples [14]. Therefore, we anticipated that fibro-
nectin degradation also might occur in burn wounds. Our studies 
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of trypsin-like or chymotrypsin-like serine proteinases. En-
zyme activity also was neutralized by antibodies against 
human neutrophil elastase. Incubation of fibronectin with 
burn wound fluid or purified human neutrophil elastase gen-
erated similar fibronectin-degradation products. Finally, di-
rect assay of burn-wound-fluid samples with a synthetic 
elastase substrate showed a correlation between fluid-phase 
elastase activity and fibronectin degradation. Based on these 
findings, we conclude that burn-wound-fluid elastase is re-
sponsible for extensive fibronectin degradation. Acute eleva-
tion of elastase did not appear to hinder normal wound repair. 
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] Invest DennatoI103:155-161, 1994 
show that burn-wound fluid contains fibronectin fragments, and 
neutrophil elastase has been identified as the enzyme responsible for 
extensive fibronectin degradation. 
MATERIALS AND METHODS 
Wound Fluid and Plasma This research project was approved by the 
University Institutional Review Board. Informed consent was obtained for 
all procedures. Burn-wound-fluid samples were collected from patients 
admitted to the burn unit of a large metropolitan hospita.l. Patients had 
sustained partial to full-thickness burns involving at least one extremity. 
Table I summarizes the patient population used in the study. 
Wound-fluid samples were collected immediately following routine 
cleansing of the burn wounds with 4 X 4 sterile gauze and Hibiclens soap 
(Stuart Pharmaceuticals). This procedure, which is routinely carried out 
with patients 1- 2 times/ d, removes the fibrous exudate that forms over 
their burn wounds. A sterile glove (gas autoclaved, Bodi-gard shoulder 
length, polyethylene glove, Hospital Therapy Products, Inc.) was applied to 
the extremity and secured at its proximal aspect with a noncompressive cling 
wrap. This was left in place 4 h, during which time burn-wound fluid 
accumulated. Subsequently, the burn fluid (5-10 ml) was drained from the 
glove. Some samples of burn fluid were sent to hematology for differential 
white blood cell counts, but numerical results were not possible because few 
intact cells were observed. 
Wound-fluid samples were centrifuged at 13,500 rpm (BeckmanJ2-21 M, 
20 rotor) for 15 min at 22°C. Supernatants were frozen in liquid No and 
stored at -70°C until use. Blood samples were obtained by venipu.ncture 
with a 21-gauge stainless steel needle attached to a blood collection device 
(Vacutainer, Becton Dickinson, Rutherford, NJ) containing ethylenedia-
minetetraacetic acid (EDTA) anticoagulant. To obtain plasma, cells were 
removed from the samples by centrifugation (1800 X g for 15 min at 22°C 
followed by 22,000 X g for 30 min at 4°C). The supernatants were filter 
sterilized using a 0.2-,um filter, and stored at -70°C until use. Protein 
concentrations were determined by the Lowry method [15]. 
.1 
SDS-PAGE and Immunoblotting Sodium dodecylsulfate - polyacryl-
amide gel electrophoresis (SDS-PAGE), immunoblotting, and cell blotting 
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Table I. Burn Patient Profi lea 
Number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Age 
21 
29 
28 
66 
77 
48 
41 
32 
51 
35 
70 
, Sec Materials alld Methods for details. 
Burn Size 
and Depth 
15%-partial 
15%-partial 
16%-partial 
30%-5% full 
20%-5% full 
77% - partial 
83%-42% deep 
15%-partial . 
30%-14% full 
8%-partial 
32%-30% full 
Sampling 
Day 
1 
5 
1 
1 
2 
8 
8 
2 
6 
3 
5 
were carried out as described previously [8]. Briefl y. samples fo r SOS-PAGE 
(16] were dissolved in red ucing sample buffer (62.5 mM Tris. 2% SDS. 10% 
glycerol. 0.01 % bromophenol blue. pH 6.8. 5% mercaptoethanol) unless 
indicated otherwise and subj ected to electrophores is on 7.5% acry lamide 
mini-gels (Bio-Rad Mini-Protean apparatus) at 22°C for 45 min and 200 V. 
Bio-Rad high molecular mass standards were used for markers. 
For immunoblotting. polypeptides separated by SDS-PAGE were trans-
ferred to nitrocellu lose paper (Schleicher & Schuell) by electrophoresis at 
22 °C for 1 b at 100 Vor at 22°C for 16 h at 34 V. T he transferred proteins 
were incubated with polyclonal anti-fibronectin antibodies for 2 h at 22°C 
fo ll owed by incubation with a l kaline-phosphatase-cO!~ugated goat anti-
rabbit IgG (Bio-Rad. Richmond. CAl fo r 1 h at 22°C. Visuallzation was 
accomplished usin g the Bio-Rad alka line-phosphatase conju gate substrate 
kit according to the manufacturer's instructions. 
For cell blotting. polypeptides separated by SDS-PAGE were transferred 
to nitroce ll ulose paper as described above. T he transferred protein strips 
were blocked with 3% bovine serum albumin (BSA) (Miles. Fraction V) in 
Tris-buffered saline (TBS) (20 mM T ris base, 0.5 M N aCl, pH 7 .5), then 
washed with TIBS (TBS + 0.05% Tween 20) fo llowed by D ulbecco's 
phosphate ·buffered saline (OPBS) (1 50 mM N aCI. 3 InM KCI. 1 mM 
CaCI2 • 0.5 mM MgCI2 • 1 mM KH 2PO • • 6 mM N a2H PO •• pH 7 .2). Baby 
hamster kidney (BHK) was cultu red overn ight with 20 )lC i/ml of 35S_ 
methionine (ICN. 1100 Ci/mmole) in methionine-de ficient OME medium 
(GIBCO). harvested. and cultured 3 - 4 h in suspension in fresh medium 
without rad iolabeled meth ionine. Each nitrocellulose strip w as incubated 
for 1 h at 37°C with 10· cells (3.25 X 10· cpm) in 0.5 ml DPBS containing 
30 mg/ml bovine serum albumin (Miles. Fraction V) . At the end of the 
incubations. unattached cells were removed by washing th ree times with 
TTBS. T he attached cells were fixed with 3% paraformaldehyde and dried 
for autoradiography. Radioactive ba nds show the locations of adhesio n-pro-
moti ng polypeptides. 
Zymography Proteinase profi les were dete rmined as described previ-
ously [9] by zymography [17]. Briefl y. samples of burn-wound fluid were 
subjected to 5DS-PAGE on gelatin-conraining acry lamide gels (7. 5% acry-
lamide and 0.5% gelatin) under non-reducing conditions. After electropho-
resis. gels were washed twice with 2.5% Triton X 100 fo r 30 min to remove 
SDS. They were then rinsed briefl y with H 20 fo llowed by incubation 
overnigh t at 37"C in reaction buffe r containing 50 111M Tris. 150 mM N aCl, 
and 5 mM CaCI2 (pH 7.4). At the end of the incubations. the ge ls were 
stained with 0.125% Coomassie brilliant blue. Areas of proteinase activi ty 
appeared as clear zones against a dark blue background, and this method 
detects metalloproteinases even if they arc still in the proenzyme form [17J . 
Elastase Determination Burn-wound fluid or plasma samples (25 -50 
Jlg) or human ncutrophil elastase (0.02-0 .2 mill iunits) were incubated 1 h at 
22°C in 1 ml of 0. 1 M Hepes buffer, pH 7.5. containing 0.5 M N aCl, 10% 
dimcthylsu lfoxidc. and 0.1 mM elastase substrate (l11cthoxysuccinyl-ala-ala-
pro-val-p-nitrioanilide) (1 8]. Substrate degradation was determined by mea-
suring 00"0 (Beckman O U-40 spectrophotomcter). A standard curve for 
dcgradation was prepared from the elastase data. which ranged from 0 to 
0.4400 uni ts. Burn fl uid and plas ma results were converted to milliunits 
(mU) of elastase activity and normalized to mg burn-fluid protein. 
Materials Human plasma fibronectin was obtained from the New York 
Blood Center. BHK cel ls were cultured as described previously [8J. Amin-
oethylbcnzencsul fony lfluoride (AEBSF). human ncutrophi l elastase (22 
un its/mg). human neutrophil catheps in G (2 units/mg). elastase substrate. 
and clastatinal were purchased from Calbiochem Co. Aprotinin . chymosta-
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Figure 1. Fibronectin profi les in burn-wound fluid . Samples (30 )lg/Iane) 
of burn-wound flui d from the patients indicated were subjected to SDS-
PAGE and analyzed by immunoblotting with anti-fibronectin . Other details 
are in Materia ls a"d Metll ods. 
tin. leupeptin. EOTA. 1.10-phenanth ro line. gelati n (bloom 225). casein. 
and plasmin (4.2 u111ts/mg) were purchased fr0111 Sigma Co. Trypsin 
(1: 250) was obtained from GIBCO. T he elastase inhibitor IC 1200.355 was 
a gift from ICI Ameticas Inc .• and the elastase inhibitor MOL 27 ,367 was a 
gift from Marion Merrell Oow Research Inst. Goat anti-humatl neutrophil 
elastase (purified IgG . 18 mg/m l) was purchased from IC N Biomedicals. 
Inc. MOlloclonal antibody 7-11 C against MMP-9 (92-kOa matrix metallo-
proteinase) was a gift from Dr. Debbie French , SUNY Sto nybrook. 
RESULTS 
Fibronectin Profiles in Burn-Wound Fluid and Plasma 
Fig ur e 1 shows immunoblo tting profiles o f fibron ectin in burn-
fl u id samples from 11 patients. Degrad atio n of fib ronectin w as ob-
served in eve ry sample. With patients 1,3 - 7,9 , and 11 , the samples 
contained seve ral bands ran gin g fro m 120 kDa to intact fibronect in. 
With p at ients 2, 8, and 10, n o intact fibronecti n remained, and t he 
major fragm ent w as 11 6 kDa. 
Figure 2 sh ows typical resul ts comparing fibronectin profiles 
(left) and cell-b lo tting pro fil es (right) o f burn flu id and p lasma f rom 
several of the patients. Cell blo tting identifies t hose fragm ents that 
contain cell adhesio n recognitio n do m ains [8,19]. P lasm a samples 
from all pat ients con tained m ostly intact fib ron ectin and vitronectin 
(65-75 kDa) . 
In wound fluid w ith partially degraded fibronectin, the 120-kDa 
and hig her - m o lecu lar- m ass fragm ents o bserved by immunoblot-
ting also could be detected by cell b lo tting. su ggesting that these 
fragm ents contained the fib ron ectin ce ll b ind in g do m ain. In sam-
ples with exte nsively degraded fibro nectin, the 116-kDa fibro nec-
tin fragm ent and a sm all er 90- kDa frag m ent also h ad cell-binding 
activ ity . Cell-blo tting studies also indicated th at vitro nectin was 
reduced or absen t in wound fluid w ith pa rtiall y degraded fibro nec-
tin and absent fro m wound fl u id w ith extensive ly degraded fib ro-
nectin. 
Proteinases in Burn-Wound Fluid In addition to adhesion 
protein fragm ents. a ll bllrn-wound - flllid samples contained p ro-
teinases that cou ld be detected by ge latin zymography [17] . The 
h ig hest activi ty w as fo und in samples 2 . 8 . and 10 [14]. which 
sho w ed t h e m ost exte nsive fibronectin degradation. Figure 3 sh ows 
resul ts fo r wound fluid sample 10 using trypsin (TR) as a contro l. In 
t h e wound fluid , th ere w ere 6 - 7 prominent gelatinase bands r ang-
ing fro m 66 k Da to m ore tha n 230 kDa. In correspo nd in g plasma 
samples. gelatinase activ ity was barely detectab le (data no t shown). 
The band migra ting at abo u t 9 7 kDa w as ide ntified at proenzym~ 
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Figure 2. Immunoblotting and cell-blotting analysis offibronectin fragments. Samples (30pg/lane) of burn-wound fluid (W) and plasma (P) from patients 4, 
7, and 10 were subjected to SDS-PAGE and analyzed by immunoblotting (left) and cell blotting (right). Positions of fibronectin (FN) and vitronectin (VN) are 
detennined with standards. Other detai ls are in Materials al/d Methods. 
MMP-9 (94-kDa type IV collagenase) by immunoblotting with 
monoclonal antibody 7-11C, and the band at about 66 kDa co-mi-
grated with mastectomy fluid MMP-2 (72-kDa type IV collagen-
ase) (data not shown) . Figure 3 also shows that all of the gelatinase 
bands were metalloproteinases because they could be inhibited by 
o-phenanthroline (o-phen), wh ich had no effect on trypsin activity. 
In contrast, trypsin was inhibited by aprotinin, which had no effect 
on wound fluid gelatinases. 
The results in Fig 3 indicated that, compared to plasma, burn-
wound fluid contains high levels of several metalloproteinases. 
B ecause zymographic analysis detects proteinases regardless of 
whether they are in the inactive proenzyme or activated enzyme 
Inhibitor : none o - phen aprotinin 
Sampl e : 
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Figure 3. Gelatinase zymography of burn-wound fluid . Samples of trypsin 
(TR) (0.2pg/lane) and patient 10 burn-wound fluid (WF) (5 pg/ lane) were 
subjected to gelatin zymography. O-phenanthroline (10 111M) (a metallo-
proteinase inhibitor) and aprotinin (20 ILg / ml) (a trypsin / serine proteinase 
inhibitor) were added to the reaction buffer where indicated. Wound-fluid 
samples from patients 2 and 8 showed identical gelatinase profiles (not 
shown). Other details are in Materials al/d Methods. 
form [17]. direct proteolysis experiments also w ere carried out. Fig-
ure 4 shows an experiment in which differen t concentrations of 
wound fluid or plasma were incubated wi th fibronectin, after w hich 
the extent of fibronectin degradation w as de termined by inun uno-
blotting . Substantial fibronectin degradation occurred after incuba-
tion with wound fluid (lalle 1, 30 flg; lalle 2, 3 flg) bnt not plasma. 
Identification of Elastase as the Proteinase in Wound Fluid 
Responsible for Fibronectin Degrada tion U sing the fib ro-
nectin proteolysis assay , w e analyzed the type of proteinase involved 
in fibronectin degradatio n. Figure 5 shows that proteolys is of fib ro-
nectin could be blocked by th e broad spectrum serine proteinase 
inhibitor AEBSF (lalle 3 compared to lalle 2). On the o th er hand, 
proteolysis was not blocked by addition o f the metall oproteinase 
W+F P+F 
F W P 
1 2 3 4 123 4 
200- FN 
Figure 4. Degradation of fib ronectin by burn-wound fluid. Samples of 
fibronectin (F) (0.22 pg) were mixed with patient 10 burn-wound fl uid (W) 
or plasma (P) in 14 ,Ill DPBS. After 5 min at 37"C the reactions were 
terminated by the addition of SDS-sa l11 ple buffer, and the samples were 
subjected to SDS-PAGE and immunobl otting with anti-fib ronectin. T he 
amounts of burn-wound fluid and plasma were 30 JIg (Ialle 1) , 3 pg (Inlle 2), 
0.3 pg (lalle 3), and 0.03 pg (lalle 4). Other details are in Materials mId 
Methods. 
Figure 5. Effects of proteinase inhibitors on fibronectin degradation by 
burn-wound fluid. Burn-wound fluid (patient 10, Sllg) in 12111 DPBS was 
preincubated for 10 min at 37"C with AEBSF (1.7 mM), aprotinin (17 
Ilg/ml),leupeptin (O.S mM), EDT A (S mM), and o-phenanthroline (S mM) 
as indicated. Subsequently, fibronectin (0.5 Ilg) in 4 III phosphate sa line 
buffer (10 mM NaH2PO., 150 mM NaCI , pH 7.2) was added to the incuba-
tions, which were allowed to continue for an additional 60 min. The reac-
tions were terminated by the addition ofSDS-sample buffer, and the samplcs 
were subjectcd to SDS-PAGE and immunoblotting with anti-fibronectin. 
Othcr details arc in Materials atld Methods. 
inhibitors o-phenanthroline and EDT A or by the addition of the 
serine proteinase inhibitors aprotinin and leupeptin. The latter 
block the trypsin class of serine proteinases but not the chymotryp-
sin or elastase-related enzymes. 
Based on the above results, it seemed likely that a serine protein-
ase in the elastase or chymotrypsin class was responsible for fibro-
nectin degradation. Therefore, we studied the possibility that burn-
wound fluid contained the enzyme elastase, which has been shown 
to degrade fibronectin ill vitro (201. Figure 6 shows a typical dose-re-
sponse experiment comparing fibronectin degradation by different 
concentrations of burn-wound fluid from patient 10 or human neu-
trophil elastase (HNE) (22 units/ mg) . The appearance of similar 
degradation profiles was consistent with a role for elastase in fibro-
ncctin degradation by burn fluid . Similar degradation patterns were 
found using burn-wound fluid from patients 2 and 8 (data not 
shown). Fibronectin degradation by 25 J1.g of wound fluid was 
equivalent to that observed with lOng (0.22 mU) of elastase. It 
could be calculated, therefore, that the elastase concentration in 
burn-wound fluid (patient 10) was - 9 mU /mg protein. (See Table 
II below.) 
Neutrophil granules that contain elastase also contain the enzyme 
cathepsin G, a chymotrypsin-related serine proteinase that can de-
grade fibronectin (211 . Therefore, we checked whether wound-
fluid cathepsin G played a role in fibronectin degradation. Figure 7 
shows an experiment comparing fibronectin degradation by elas-
tase, cathepsin G, and wound fluid in the presence of specific inhibi-
tors of neutrophil elastase, ICI 200,355 [22] , and MDL 27,367 [23], 
or in the presence of chymostatin, an inhibitor of chymotrypsin-re-
lated serine proteinase. The ICI and MDL compounds inhibited 
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Figure 6. Comparison of fibroncctin dcgradation by burn-wound fluid and 
human neutrophil elastase. Samples of fibronectin (0.5Ilg) were mixcd with 
patient 10 burn wound fluid (WF) or human ncutrophil elastase (HNE) at 
the concentrations indicated in 22 III DPBS. After 60 min at 37'C the 
reactions were terminated by thc addition of SOS-sample buffer, and the 
samples were subjected to SDS-PAGE and immunoblotting with anti-
fibronectin. Other details arc in Materials atJd Methods. 
fibronectin degradation by elastase but not by cathepsin G, whereas 
chymostatin inhibited fibronectin degradation by cathepsin G but 
not by elastase. In related experiments, samples of wound fluid 
(patient 10), elastase, and cathepsin G were incubated with poly-
clonal antibodies against human neutrophil elastase and then tested 
for fibronectin degradation. Addition of antibody (9 f1g IgG) com-
pletely neutralized fibronectin degradation by 4 ng neutrophil elas-
tase or 5 J1.g wound fluid but had no effect on fibronectin degrada-
tion by cathepsin G (2-1 2 ng). 
Immunoblotting experiments aimed at correlating elastase levels 
in wound fluid with fibronectin degradation were not possible be-
cause elastase levels were too low (relative to total protein) to permit 
detection. It was possible, however, to correlate the extent of bUIIl-
wound-fluid fibronectin degradation with fluid-phase elastase ac-
tivity using a spectrophotometric method (18]. Table II shows tbat 
high elastase levels occurred in burn-wound fluids with extensively 
Table II. Elastase Activity in Burn-Fluid Sample.s" 
Experiment 
2 
Sample 
10-BF 
10-PL 
2-BF 
S-BF 
lO-BF 
6-BF 
7-BF 
9-BF 
Elastase Activity 
(mU/mg sample) 
14.6 ± 1 
< 1 
7.2 ± 0.4 
6.0 ± 0.4 
14.5 ± 0.4 
< 1 
1.6 ± 1.6 
<1 
• Samples of burn-wound fluid (DF) or plasma (PL) from the patients indicated WOIr 
incubated with elastase substrate. Substrate degradation was determined by measuring 
00" •. The results were converted to milliunits (mU) of elastase based 011 a standanl 
curve and nonnalizcd to protein concentration. Data shown arc averages ± so &om 
duplicate determinations. Other details arc in Materials alld Met/,ods. 
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Figure 7. Effect of elastase inhibitors on fibronectin degra-
dation by burn-wound fluid, human neutrophil elastase, and 
human cathepsin G. Samples of elastase (2 ng), cathepsin G 
(2 ng), or patient 10 burn fluid (5I1g) as indicated were prein-
cubated with ICI 200,355 (10 JlM), MOL 27,367 (20 11M), or 
chym.ostatin (200 11M) in 17 Jll OPBS. AfterlO min ~t 37 °C, 
fibronectin (O.5l1g) was added to the incubatIOns, wluch were 
allowed to continue for an additional 60 min. The reactions 
were terminated by the addition of 50S-sample buffer, and 
the samples were subjected to 50S-PAGE and immunoblot-
ring with anti-fibronectin. Other details are in Materials a"d 
Methods. 
ICI 
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degraded fibronectin (patients 2, S, and 10) whereas low or unde-
tectable elastase activity occurred in burn-wound fluids with mini-
mally degraded fibronectin (patients 6, 7, and 9). (See Fig 1.) No 
elastase activity was detectable in 25 - 50-,ug samples of plasma. The 
level of burn wound fluid elastase measured by the spectrophoto-
metric assay (6 -15 mU Img) corresponded well with the level of 
elastase measured by the fibronectin degradation assay (- 9 mU I 
mg) (Fig 6). 
Effect of Burn Wound Fluid on Cell Spreading Taken to-
gether, the results described above show that elastase was the pro-
teinase in burn fluid responsible for degradation of fibronectin. Be-
cause fibronectin plays an important role in cell adhesion during 
wound repair [3 ,4) we tested whether burn-wound fluid elastase 
could inhibit cell adhesion. BHK fibroblasts were allowed to attach 
and spread on fibronectin-coated culture dishes (Fig SA) . Figure 8B 
shows that the addition of burn fluid to the previously spread BHK 
cells caused cell rounding, and that this activity could be neutralized 
by the elastase inhibitors leI 200,355 (Fig 8e) or MDL 27,367 
(data not shown). These data indicate that burn fluid elastase can 
interfere with cell adhesion to fibronectin. 
DISCUSSION 
To learn more about the wound-healing process, we have been 
using wound fluid as a non-invasive method to characterize adhe-
sion proteins and proteinases in the wound environment. In the 
present studies, we analyzed burn-wound fluid to learn if fibronec-
tin degradation occurred in acute traumatic wounds. Immunoblot-
ting experiments showed that burn fluid contained degraded fibro-
nectin. In some samples, degradation resulted in a mixture of intact 
fibronectin molecules and fragments 120 kDa and larger. In others, 
intact fibronectin molecules were absent, and the largest frag-
ment was 116 kDa. The 116-kDa fragment as well as a smaller 
90-kDa fragment both contained the fibroblast cell binding 
domain. 
Wound-fluid samples containing extensively degraded fibronec-
rin contained a proteinase capable of degrading freshly added fibro-
nectin. Activity of the enzyme was blocked by a broad spectrum 
serine proteinase inhibitor and by specific inhibitors of neutrophil 
elastase but not by metalloproteinase inhibitors or inhibitors of 
trypsin-like or chymotrypsin-like serine proteinases. Moreover, 
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wound-fluid fibronectin-degradation activity was neutralized by 
antibodies against human neutrophil elastase. Incubation of fibro-
nectin with burn-wound fluid or purified human neutrophil elas-
tase generated similar fibronectin degradation products, and direct 
assay of burn-wound fluid samples with a synthetic elastase substrate 
showed a correlation between elastase activity and fibronectin deg-
radation. These findings suggest that neutrophil elastase is the fi-
bronectin-degrading proteinase in wound fluid . In addition to elas-
tase, neutrophils contain an elastase-like enzyme called proteinase 3, 
whose broad range of substrates includes fibronectin [24,25). Our 
results cannot exclude the possibiliry that proteinase 3 also plays a 
role in fibronectin degradation in burn-wound fluid. 
A role for burn-fluid elastase in fibronectin degradation is con-
sistent with other findings, e.g., the release of elastase from neutro-
phils, which occurs as part of the inflammatory response [26,27)' 
and reported ability of elastase to degrade fibronectin in vitro [20]. 
Moreover, adding activated neutrophils to cell cultures in vitro re-
sults in elastase-dependent degradation of extracellular matrix fi-
bronectin and cell detachment [28 - 30) . In our studies, burn-
wound - fluid elastase inhibited fibroblast adhesion to fibronectin. 
Finally, degradation of fibronectin by elastase has been described in 
bronchial secretions from patients with cystic fibrosis (31) and em-
physema (32). 
Other investigators reported that elevated elastase levels occur in 
patient serum 24 h following burn injury that are greater than 40% 
TBSA (33). Using a similar assay method, but approximately 100-
times smaller samples, we detected elastase activity in patient 
wound fluid but not in plasma. It seems likely, therefore, that elas-
tase in wound fluid is released locally by neutrophils in the wound 
matrix, not derived from the circulation. Moreover, there arc suffi-
cient levels of ai-proteinase inhibitor to neutralize elastase released 
into the plasma after burn injury (34), whereas some burn-wound 
fluid samples were found to have markedly reduced levels of elastase 
inhibitor [35]. The presence of active elasta~e at the wound site 
indicates an imbalance between the proteinase and its serum inhibi-
tors. We have yet to determine whether this imbalance occurs be-
cause local elastase release by neutrophils sometimes exceeds wound 
proteinase inhibitor capacity or because there are decreased levels of 
proteinase inhibitors at the wound site. 
Previous studies on chronic wound fluid had led us to anticipate 
that gelatinases might playa role i11 fibronectin degradation [9,14). 
The present results suggest that although MMP-9 and other gela-
tinases are elevated in wound fluid samples containing degraded 
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Figure 8. Reversal of cell spreading by wound fluid and the effect of elas-
tase inhibitors. Culture dishes were coated with fibronectin (10 ttg/ml in 
DPBS) and then incubated 2 h w ith BHKcelis in DMEM medium (GIBCO) 
and 10% fetal bovine serum during which time cell spreading occurred. 
Subsequently, the incubations were continued for an additional 90 min in 
DMEM containing (A) 10% serum; (B) 2 mg/ml bum-wound fluid 10; or 
(C) 2 mg/ml burn-wound fluid 10 with 10 ttM lCI 200,355 . The final 
DMSO concentration in all samples was 2%. At the end of the incubations, 
samples were photographed using a Zeiss inverted microscope. Bar, 40 ttM. 
fibronectin, these enzymes probably are not responsible for fibro-
nectin degradation. The observation that both elastase and MMP-9 
are increased in wound fluid is consistent with neutrophils as the 
source for elastase and cathepsin G [26] as well as MMP-9 [36,37]. In 
burn-fluid samples with partially degraded fibronectin, the protein-
ase responsible for fibronectin degradation has yet to be identified. 
Based on differences in the fibronectin degradation profiles, it ap-
pears that different enzymes or combinations of enzymes result in 
partial and extensive degradation of fibronectin. Therefore, gelatin-
ases or other metalloproteinases might be involved. 
Five of the 11 patients (1,2, 3, 8, and 10) were discharged from 
the burn unit within 2 weeks after injury without requiring surgical 
intervention. Of these, three had extensively degraded fibronectin 
on the day their burn-wound fluid was sampled. Therefore, degra-
dation of fibronectin, even extensive degradation, is not by itself an 
indicator of non-healing conditions. Transient fibronectin degrada-
tion might even be beneficial because some fibronectin fragments 
have unique biologic activities that could promote repair, e.g., 
through chemoattraction of monocytes [38,39] or by increasing 
monocyte phagocytic activity [40] , neutrophil adhesiveness [41], 
and fibroblast proliferation [42]. 
Although acute elevation of elastase did not appear to hinder 
wound repair, chronically high levels of elastase would likely have 
pathophysiologic consequences including degradation of the der-
mal/epidermal junction [43]. As shown in this study, burn-fluid 
elastase can interfere with fibroblast adhesion to fibronectin. Per-
sistent elastase-mediated degradation of extracellular matrix com-
ponents in the wound bed could account for leukocyte-mediated 
chronic wound damage [44] and might playa role in development 
of chronic skin ulcers [11]. In future studies using longitudinally 
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collected burn wound fluid samples, we hope to learn more about 
the regulation of elastase and other proteinases in wound fluid. 
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assistallce lVith bum patieflts, afld to Ms. Elise Tid,vclJ R.N., who col/ected lhe 
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